Evidence map›Paper›PMID 42472741›Full record

ArticleHeart and vessels2026

Author's Reply to "Microvascular angina beyond risk markers: the need for endotype-specific validation".

Satoru Suzuki, Kenichi Tsujita

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Satoru SuzukiDepartment of Cardiovascular Medicine, Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto City, 860-8556, Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto City, 860-8556, Japan. tsujita@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0002-4314-259X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We thank Birgün et al. for their thoughtful comments regarding our recent study on microvascular angina (MVA). In this reply, we address concerns regarding the selection of control group, medication-related confounding, and the heterogeneity of MVA endotypes. We acknowledge the limitations inherent to our retrospective case-control design while emphasizing that the observed associations between mildly elevated HbA1c, low high-density lipoprotein cholesterol, low hemoglobin levels, and MVA remained significant. We hope that these findings will stimulate further prospective investigations into the pathophysiology and clinical characteristics of MVA.

Indexed as

Case-control studyCoronary microvascular dysfunctionMicrovascular angina

Identifiers

PMID42472741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.